Time course of plasticity-related alterations following the first exposure to amphetamine in juvenile rats
Copyright © 2022 Elsevier Inc. All rights reserved..
In vulnerable consumers, the first drug exposure induces various neurobehavioral adaptations that may represent the starting point toward addiction. Elucidating the neuroplastic mechanisms underlying that first rewarding experience would contribute to understanding the transition from recreational to compulsive drug use. In a preclinical model with juvenile rats, we analyzed the time-dependent fluctuations in the expression of neuroplasticity-related genes like the brain-derived neurotrophic factor (BDNF), its tropomyosin receptor kinase B (TrkB), the cAMP response element-binding protein (CREB), the microRNA-132, the Rho GTPase-activating protein 32 (p250GAP), the corticotropin-releasing factor (CRF), and the neurotransmitters contents in the nucleus accumbens (NAc) and the dorsal striatum (DS) 45, 90, and 180 min after an amphetamine (AMPH) injection. As expected, AMPH altered the concentration of norepinephrine, dopamine, DOPAC, and serotonin in a region- and time-dependent manner. Regarding gene expression, AMPH at 45 min upregulated BDNF and primiR-132 expression in NAc and downregulated TrkB expression in DS. At 90 min, AMPH upregulated TrkB, CREB, p250GAP, and primiR-132 expression in NAc and BDNF, primiR-132, and CRF in DS. At 180 min, only BNDF in NAc continued to be upregulated by AMPH. Based on the levels of AMPH-induced hyperactivity, we classified the rats as low and high AMPH responders. High AMPH responders characterized by overexpressing BDNF, CREB, p250GAP, and CRF in NAc and by showing lower levels of dopamine and serotonin metabolites and turnovers in both regions. Our findings demonstrated that a single AMPH administration is enough to induce neuroplastic adaptations, especially in the NAc of prone rats.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:221 |
---|---|
Enthalten in: |
Pharmacology, biochemistry, and behavior - 221(2022) vom: 01. Nov., Seite 173489 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sequeira-Cordero, Andrey [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 06.12.2022 Date Revised 13.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.pbb.2022.173489 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM348890907 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM348890907 | ||
003 | DE-627 | ||
005 | 20231226041334.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.pbb.2022.173489 |2 doi | |
028 | 5 | 2 | |a pubmed24n1162.xml |
035 | |a (DE-627)NLM348890907 | ||
035 | |a (NLM)36375621 | ||
035 | |a (PII)S0091-3057(22)00168-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sequeira-Cordero, Andrey |e verfasserin |4 aut | |
245 | 1 | 0 | |a Time course of plasticity-related alterations following the first exposure to amphetamine in juvenile rats |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 06.12.2022 | ||
500 | |a Date Revised 13.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Elsevier Inc. All rights reserved. | ||
520 | |a In vulnerable consumers, the first drug exposure induces various neurobehavioral adaptations that may represent the starting point toward addiction. Elucidating the neuroplastic mechanisms underlying that first rewarding experience would contribute to understanding the transition from recreational to compulsive drug use. In a preclinical model with juvenile rats, we analyzed the time-dependent fluctuations in the expression of neuroplasticity-related genes like the brain-derived neurotrophic factor (BDNF), its tropomyosin receptor kinase B (TrkB), the cAMP response element-binding protein (CREB), the microRNA-132, the Rho GTPase-activating protein 32 (p250GAP), the corticotropin-releasing factor (CRF), and the neurotransmitters contents in the nucleus accumbens (NAc) and the dorsal striatum (DS) 45, 90, and 180 min after an amphetamine (AMPH) injection. As expected, AMPH altered the concentration of norepinephrine, dopamine, DOPAC, and serotonin in a region- and time-dependent manner. Regarding gene expression, AMPH at 45 min upregulated BDNF and primiR-132 expression in NAc and downregulated TrkB expression in DS. At 90 min, AMPH upregulated TrkB, CREB, p250GAP, and primiR-132 expression in NAc and BDNF, primiR-132, and CRF in DS. At 180 min, only BNDF in NAc continued to be upregulated by AMPH. Based on the levels of AMPH-induced hyperactivity, we classified the rats as low and high AMPH responders. High AMPH responders characterized by overexpressing BDNF, CREB, p250GAP, and CRF in NAc and by showing lower levels of dopamine and serotonin metabolites and turnovers in both regions. Our findings demonstrated that a single AMPH administration is enough to induce neuroplastic adaptations, especially in the NAc of prone rats | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Dopamine | |
650 | 4 | |a Drug dependence | |
650 | 4 | |a Locomotion | |
650 | 4 | |a Plasticity | |
650 | 4 | |a Psychostimulant drugs | |
650 | 4 | |a Reward | |
650 | 7 | |a Amphetamine |2 NLM | |
650 | 7 | |a CK833KGX7E |2 NLM | |
650 | 7 | |a Brain-Derived Neurotrophic Factor |2 NLM | |
650 | 7 | |a Dopamine |2 NLM | |
650 | 7 | |a VTD58H1Z2X |2 NLM | |
650 | 7 | |a Corticotropin-Releasing Hormone |2 NLM | |
650 | 7 | |a 9015-71-8 |2 NLM | |
650 | 7 | |a Serotonin |2 NLM | |
650 | 7 | |a 333DO1RDJY |2 NLM | |
650 | 7 | |a Central Nervous System Stimulants |2 NLM | |
650 | 7 | |a MIRN132 microRNA, rat |2 NLM | |
650 | 7 | |a MicroRNAs |2 NLM | |
700 | 1 | |a Brenes, Juan C |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmacology, biochemistry, and behavior |d 1973 |g 221(2022) vom: 01. Nov., Seite 173489 |w (DE-627)NLM000022721 |x 1873-5177 |7 nnns |
773 | 1 | 8 | |g volume:221 |g year:2022 |g day:01 |g month:11 |g pages:173489 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pbb.2022.173489 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 221 |j 2022 |b 01 |c 11 |h 173489 |